Evidence map›Paper›PMID 32895130›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2020

[Effects of advanced glycation end products on osteoclasts at different stages of differentiation].

Xiaoqian Ding, Yun Hu, Dan Luo, Yu Tang, Caiyu Li, Leilei Zheng

Open access · greenAbstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. The role of wnt signaling in diabetes-induced osteoporosis.Diabetology & metabolic syndrome · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaoqian DingAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Yun HuAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Dan LuoAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Yu TangAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Caiyu LiAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Leilei ZhengAffiliated Stomatology Hospital, Chongqing Medical University, Chongqing 401145, China.
Chongqing University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo explore the effect of advanced glycation end products (AGEs) on osteoclasts at different stages of differentiation.

methodsRaw264.7 cells cultured

resultsWe defined the initial 3 days of induction as the early stage of differentiation and the time beyond 3 days as the late stage of differentiation of Raw264.7 cells. Intervention with AGEs at 100 mg/L produced no significant effects on the viability of the cells, but AGEs suppressed the cell proliferation at a concentration exceeding 100 mg/L. The number of osteolasts in the early- and late-stage intervention groups was greater than that in the control group, but the cell count differed significantly only between the early-stage intervention group and control group (

conclusionsAGEs can affect the differentiation of osteoclasts differently when applied at different stages, and intervention with AGEs at the early stage produces stronger effect to promote osteoclast differentiation than its application at a late stage.

Indexed as

Bone ResorptionOsteoclastsAnimalsCell DifferentiationMiceRANK LigandRAW 264.7 CellsReceptor Activator of Nuclear Factor-kappa BRANK LigandReceptor Activator of Nuclear Factor-kappa Badvanced glycation end productsdifferentiationosteoclastRaw264.7 macrophages

Identifiers

PMID32895130
PMCPMC7225107
OpenAlexW3084186981

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.